0001209191-20-006956.txt : 20200205 0001209191-20-006956.hdr.sgml : 20200205 20200205165134 ACCESSION NUMBER: 0001209191-20-006956 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200203 FILED AS OF DATE: 20200205 DATE AS OF CHANGE: 20200205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20579479 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-03 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Chief Patient Officer Common Stock 2020-02-03 4 M 0 2156 91.05 A 38346 D Common Stock 2020-02-03 4 M 0 1941 86.52 A 40287 D Common Stock 2020-02-03 4 S 0 500 228.89 D 39787 D Common Stock 2020-02-03 4 S 0 714 230.07 D 39073 D Common Stock 2020-02-03 4 S 0 1306 231.25 D 37767 D Common Stock 2020-02-03 4 S 0 1177 231.92 D 36590 D Common Stock 2020-02-03 4 S 0 400 232.87 D 36190 D Common Stock 882 I 401(k) Common Stock 16190 I Held in trust Stock Option (Right to Buy) 91.05 2020-02-03 4 M 0 2156 0.00 D 2026-02-01 Common Stock 2156 0 D Stock Option (Right to Buy) 86.52 2020-02-03 4 M 0 1941 0.00 D 2027-02-02 Common Stock 1941 7767 D Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $228.89 (range $228.37 to $229.12). Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $230.07 (range $229.48 to $230.47). Open market sales reported on this line occurred at a weighted average price of $231.25 (range $230.53 to $231.50). Open market sales reported on this line occurred at a weighted average price of $231.92 (range $231.54 to $232.50). Open market sales reported on this line occurred at a weighted average price of $232.87 (range $232.67 to $233.31). Fully vested. The option vests in 16 quarterly installments from 02/03/2017. /s/ Omar White, Attorney-in-Fact 2020-02-05